Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients.
Yamamoto E, Fujisawa S, Hagihara M, Tanaka M, Fujimaki K, Kishimoto K, Hashimoto C, Itabashi M, Ishibashi D, Nakajima Y, Tachibana T, Kawasaki R, Kuwabara H, Koharazawa H, Yamazaki E, Tomita N, Sakai R, Fujita H, Kanamori H, Ishigatsubo Y. Yamamoto E, et al. Among authors: ishibashi d. Cancer Sci. 2014 Jan;105(1):105-9. doi: 10.1111/cas.12321. Epub 2014 Jan 23. Cancer Sci. 2014. PMID: 24450386 Free PMC article.
Drug-induced liver injury after allogeneic bone marrow transplantation.
Tachibana T, Nozaki A, Enaka M, Yamamoto E, Kawasaki R, Koharazawa H, Hagihara M, Ishibashi D, Nakajima Y, Kuwabara H, Tomita N, Ishigatsubo Y, Fujisawa S. Tachibana T, et al. Among authors: ishibashi d. Int J Hematol. 2013 Oct;98(4):499-503. doi: 10.1007/s12185-013-1434-5. Epub 2013 Sep 15. Int J Hematol. 2013. PMID: 24037455
Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era.
Watanabe R, Tomita N, Itabashi M, Ishibashi D, Yamamoto E, Koyama S, Miyashita K, Takahashi H, Nakajima Y, Hattori Y, Motohashi K, Takasaki H, Ohshima R, Hashimoto C, Yamazaki E, Fujimaki K, Sakai R, Fujisawa S, Motomura S, Ishigatsubo Y. Watanabe R, et al. Among authors: ishibashi d. Eur J Haematol. 2014 Mar;92(3):204-10. doi: 10.1111/ejh.12221. Epub 2013 Nov 28. Eur J Haematol. 2014. PMID: 24283206
Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma patients.
Tomita N, Kodama F, Tsuyama N, Sakata S, Takeuchi K, Ishibashi D, Koyama S, Ishii Y, Yamamoto W, Takasaki H, Hagihara M, Kuwabara H, Tanaka M, Hashimoto C, Yamazaki E, Koharazawa H, Fujimaki K, Sakai R, Fujisawa S, Ishigatsubo Y. Tomita N, et al. Among authors: ishibashi d. Hematol Oncol. 2015 Mar;33(1):9-14. doi: 10.1002/hon.2136. Epub 2014 Feb 11. Hematol Oncol. 2015. PMID: 24519501 Clinical Trial.
Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone.
Tomita N, Takasaki H, Ishiyama Y, Kishimoto K, Ishibashi D, Koyama S, Ishii Y, Takahashi H, Numata A, Watanabe R, Tachibana T, Ohshima R, Hagihara M, Hashimoto C, Takemura S, Taguchi J, Fujimaki K, Sakai R, Motomura S, Ishigatsubo Y. Tomita N, et al. Among authors: ishibashi d. Leuk Lymphoma. 2015 Mar;56(3):725-9. doi: 10.3109/10428194.2014.931953. Epub 2014 Aug 6. Leuk Lymphoma. 2015. PMID: 24913502
Prognostic significance of serum beta-2 microglobulin level in Hodgkin lymphoma treated with ABVD-based therapy.
Nakajima Y, Tomita N, Watanabe R, Ishiyama Y, Yamamoto E, Ishibashi D, Itabashi M, Koyama S, Takahashi H, Numata A, Takasaki H, Kawasaki R, Kuwabara H, Tanaka M, Hashimoto C, Fujimaki K, Sakai R, Motomura S, Ishigatsubo Y. Nakajima Y, et al. Among authors: ishibashi d. Med Oncol. 2014 Sep;31(9):185. doi: 10.1007/s12032-014-0185-3. Epub 2014 Aug 21. Med Oncol. 2014. PMID: 25142947
Successful Engraftment and Durable Graft-versus-host Disease Control with Haploidentical Peripheral Blood and a Short-term Conditioning Regimen for Primary Graft Failure.
Tachibana T, Yamamoto E, Kawasaki R, Koharazawa H, Ishibashi D, Nakajima Y, Tanaka M, Matsumoto K, Ishigatsubo Y, Fujisawa S. Tachibana T, et al. Among authors: ishibashi d. Intern Med. 2015;54(21):2749-52. doi: 10.2169/internalmedicine.54.4809. Epub 2015 Nov 1. Intern Med. 2015. PMID: 26521905 Free article.
Serum ferritin level is a prognostic marker in patients with peripheral T-cell lymphoma.
Koyama S, Fujisawa S, Watanabe R, Itabashi M, Ishibashi D, Ishii Y, Hattori Y, Nakajima Y, Motohashi K, Takasaki H, Kawasaki R, Hashimoto C, Yamazaki E, Koharazawa H, Takemura S, Tomita N, Sakai R, Motomura S, Nakajima H. Koyama S, et al. Among authors: ishibashi d. Int J Lab Hematol. 2017 Feb;39(1):112-117. doi: 10.1111/ijlh.12592. Epub 2016 Nov 24. Int J Lab Hematol. 2017. PMID: 27885817 Clinical Trial.
57 results